Plasma Volume Expander [EPC]

Plasma Volume Expander [EPC] was reported 3094 times

Drugs of the Plasma Volume Expander [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EYE OPERATION COMPLICATION 19 0.1159
1 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 8 0.1000
2 DEAFNESS PERMANENT 16 0.0816
3 FUNGURIA 3 0.0811
4 HYALOSIS ASTEROID 3 0.0732
5 BURKHOLDERIA TEST POSITIVE 7 0.0565
6 ENDOCRINE OPHTHALMOPATHY 48 0.0553
7 AUTOPHONY 4 0.0533
8 PUNCTAL PLUG INSERTION 3 0.0429
9 ANTI-THYROID ANTIBODY INCREASED 5 0.0397
10 PERSISTENT CORNEAL EPITHELIAL DEFECT 4 0.0339
11 PLATELET AGGREGATION INHIBITION 3 0.0326
12 PERIORBITAL PAIN 23 0.0272
13 CORNEAL INFILTRATES 6 0.0191
14 KERATITIS BACTERIAL 3 0.0184
15 EYELID PAIN 36 0.0177
16 CORNEAL EPITHELIUM DEFECT 10 0.0172
17 CORNEAL THINNING 4 0.0156
18 KERATITIS FUNGAL 3 0.0144
19 KERATOCONJUNCTIVITIS SICCA 5 0.0136
20 VERY LOW DENSITY LIPOPROTEIN INCREASED 3 0.0135
21 IMPAIRED FASTING GLUCOSE 4 0.0131
22 CORNEAL PERFORATION 8 0.0127
23 TYPE V HYPERLIPIDAEMIA 6 0.0123
24 DEAFNESS NEUROSENSORY 39 0.0118
25 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
26 EPIDERMOLYSIS 5 0.0109
27 EPIRETINAL MEMBRANE 3 0.0108
28 PRODUCT INFORMATION CONTENT COMPLAINT 3 0.0108
29 CERUMEN IMPACTION 9 0.0098
30 FOREIGN BODY SENSATION IN EYES 61 0.0096
31 OTITIS MEDIA ACUTE 7 0.0095
32 CATARACT NUCLEAR 6 0.0090
33 EYE INFECTION BACTERIAL 5 0.0090
34 PNEUMONIA MYCOPLASMAL 7 0.0088
35 CORNEAL OPACITY 12 0.0088
36 KERATITIS 25 0.0082
37 CORNEAL DEPOSITS 6 0.0081
38 CORNEAL SCAR 4 0.0080
39 CORNEAL EROSION 4 0.0074
40 EUSTACHIAN TUBE DYSFUNCTION 4 0.0069
41 EYE ULCER 4 0.0069
42 EYE PAIN 384 0.0068
43 CORNEAL ABRASION 9 0.0066
44 CORNEAL TRANSPLANT 5 0.0064
45 GROWTH OF EYELASHES 5 0.0063
46 CORNEAL OEDEMA 14 0.0062
47 ABNORMAL SENSATION IN EYE 26 0.0060
48 CORNEAL DISORDER 13 0.0059
49 SCLERAL HYPERAEMIA 4 0.0059
50 OCULAR DISCOMFORT 65 0.0058
51 NEUROENDOCRINE CARCINOMA 4 0.0058
52 INTRAOCULAR PRESSURE DECREASED 3 0.0057
53 INSTILLATION SITE ERYTHEMA 3 0.0057
54 FOREIGN BODY IN EYE 5 0.0052
55 OPHTHALMIC HERPES SIMPLEX 3 0.0052
56 PAPILLARY THYROID CANCER 9 0.0052
57 GRAFT COMPLICATION 3 0.0051
58 ULCERATIVE KERATITIS 14 0.0051
59 EYE BURNS 3 0.0051
60 MEAN PLATELET VOLUME INCREASED 3 0.0050
61 EYE IRRITATION 286 0.0050
62 RADICULOPATHY 13 0.0049
63 OPEN ANGLE GLAUCOMA 3 0.0049
64 ASTHENOPIA 26 0.0047
65 DEAFNESS BILATERAL 8 0.0047
66 THYROXINE FREE INCREASED 3 0.0047
67 HEPATIC HAEMORRHAGE 4 0.0047
68 CHOROIDAL NEOVASCULARISATION 4 0.0047
69 VITREOUS DETACHMENT 10 0.0046
70 DRY AGE-RELATED MACULAR DEGENERATION 5 0.0045
71 BLOOD ALBUMIN INCREASED 4 0.0045
72 KERATOPATHY 7 0.0044
73 PUNCTATE KERATITIS 4 0.0044
74 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
75 PHOTOPHOBIA 79 0.0042
76 INSTILLATION SITE PAIN 10 0.0040
77 BLEPHARITIS 16 0.0040
78 LIVE BIRTH 33 0.0039
79 REACTION TO PRESERVATIVES 3 0.0037
80 SUPERFICIAL INJURY OF EYE 4 0.0037
81 SOFT TISSUE DISORDER 4 0.0036
82 EYELID IRRITATION 9 0.0036
83 MEAN PLATELET VOLUME DECREASED 3 0.0036
84 VITREOUS OPACITIES 3 0.0036
85 ERYTHEMA OF EYELID 19 0.0035
86 SENSITIVITY OF TEETH 6 0.0035
87 EYE DISCHARGE 36 0.0035
88 OVARIAN HYPERSTIMULATION SYNDROME 8 0.0034
89 PRODUCT USE COMPLAINT 54 0.0034
90 CONJUNCTIVITIS ALLERGIC 5 0.0034
91 CONJUNCTIVAL HYPERAEMIA 12 0.0034
92 ANAEMIA OF CHRONIC DISEASE 3 0.0033
93 MUCOSAL EROSION 3 0.0033
94 EYE ALLERGY 5 0.0032
95 LACRIMATION INCREASED 95 0.0031
96 NASAL ULCER 5 0.0031
97 EYELID MARGIN CRUSTING 9 0.0031
98 THORACIC VERTEBRAL FRACTURE 9 0.0030
99 EYELID DISORDER 7 0.0030
100 OCULAR HYPERAEMIA 140 0.0029
101 EYE COLOUR CHANGE 3 0.0029
102 CARBON DIOXIDE INCREASED 4 0.0029
103 EYE INFLAMMATION 28 0.0029
104 BLOOD CHLORIDE INCREASED 5 0.0029
105 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
106 HYDROCELE 3 0.0028
107 EXOPHTHALMOS 6 0.0028
108 MONOCYTE COUNT INCREASED 10 0.0028
109 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
110 MEAN CELL HAEMOGLOBIN DECREASED 5 0.0027
111 ESSENTIAL HYPERTENSION 5 0.0027
112 BLOOD CHLORIDE DECREASED 7 0.0027
113 PHYSICAL DISABILITY 12 0.0027
114 ASTIGMATISM 4 0.0026
115 CARBON DIOXIDE DECREASED 3 0.0026
116 DRY EYE 130 0.0026
117 BLOOD SODIUM INCREASED 7 0.0026
118 MEAN CELL VOLUME DECREASED 4 0.0026
119 SWELLING OF EYELID 16 0.0025
120 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
121 NIGHT BLINDNESS 4 0.0025
122 EYELID SKIN DRYNESS 3 0.0025
123 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
124 HERPES OPHTHALMIC 3 0.0023
125 EYELIDS PRURITUS 7 0.0022
126 RHINITIS ALLERGIC 10 0.0022
127 HAEMATOCRIT INCREASED 5 0.0022
128 INFUSION SITE RASH 3 0.0022
129 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
130 VITRITIS 4 0.0022
131 INFUSION SITE INFECTION 5 0.0021
132 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 3 0.0021
133 LYMPHOCYTE COUNT INCREASED 7 0.0021
134 NASAL OBSTRUCTION 4 0.0021
135 AUDITORY DISORDER 3 0.0021
136 EYE SWELLING 78 0.0021
137 OCULAR HYPERTENSION 4 0.0021
138 NORMOCYTIC ANAEMIA 3 0.0020
139 MEAN CELL VOLUME INCREASED 5 0.0019
140 EYE PRURITUS 65 0.0019
141 PRODUCT DEPOSIT 3 0.0019
142 ONYCHOLYSIS 3 0.0019
143 OSTEOSCLEROSIS 3 0.0019
144 OPHTHALMOPLEGIA 3 0.0019
145 INTERMITTENT CLAUDICATION 3 0.0019
146 ENDOMETRIOSIS 9 0.0019
147 PROTEIN TOTAL INCREASED 5 0.0019
148 METABOLIC ALKALOSIS 3 0.0019
149 PARANASAL SINUS DISCOMFORT 7 0.0018
150 OPTIC ATROPHY 3 0.0018
151 VITREOUS FLOATERS 18 0.0018
152 RHINALGIA 5 0.0018
153 OTITIS MEDIA 6 0.0018
154 MEAN CELL HAEMOGLOBIN INCREASED 3 0.0018
155 INTRAOCULAR PRESSURE INCREASED 23 0.0018
156 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
157 PERIORBITAL SWELLING 10 0.0018
158 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
159 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
160 DEVICE ALARM ISSUE 3 0.0017
161 IMPAIRED QUALITY OF LIFE 23 0.0016
162 RETINAL OEDEMA 3 0.0016
163 GINGIVAL RECESSION 3 0.0016
164 EYE INFECTION 17 0.0015
165 SUBDURAL HAEMORRHAGE 4 0.0015
166 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
167 CAROTID ARTERY STENOSIS 5 0.0014
168 MACULAR OEDEMA 8 0.0014
169 NEUROGENIC BLADDER 3 0.0014
170 BRONCHIOLITIS 5 0.0014
171 LYMPHOCYTOSIS 3 0.0014
172 HORDEOLUM 6 0.0014
173 EYELID OEDEMA 16 0.0014
174 EAR DISCOMFORT 14 0.0014
175 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
176 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
177 ENDOPHTHALMITIS 8 0.0013
178 PRE-EXISTING CONDITION IMPROVED 8 0.0013
179 NEUTROPHIL COUNT INCREASED 13 0.0013
180 EOSINOPHIL COUNT DECREASED 3 0.0013
181 URINE OUTPUT DECREASED 11 0.0013
182 EYE OEDEMA 3 0.0012
183 VISION BLURRED 167 0.0012
184 VISUAL ACUITY REDUCED 40 0.0012
185 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
186 HYPERPARATHYROIDISM SECONDARY 3 0.0012
187 OSTEITIS 3 0.0012
188 EXCORIATION 3 0.0012
189 ANGLE CLOSURE GLAUCOMA 3 0.0012
190 PURULENT DISCHARGE 5 0.0012
191 VITAMIN D DECREASED 10 0.0012
192 PRODUCT CONTAINER ISSUE 10 0.0012
193 FAILURE TO THRIVE 6 0.0012
194 PRODUCT ADMINISTRATION ERROR 23 0.0011
195 BLOOD UREA INCREASED 19 0.0011
196 NASAL DISORDER 3 0.0011
197 ELECTROLYTE IMBALANCE 13 0.0011
198 EAR CONGESTION 3 0.0011
199 PHOTOPSIA 7 0.0011
200 ABDOMINAL RIGIDITY 3 0.0011
201 MAJOR DEPRESSION 8 0.0011
202 RED BLOOD CELL COUNT INCREASED 3 0.0011
203 VITREOUS HAEMORRHAGE 3 0.0011
204 EYE OPERATION 5 0.0011
205 RASH MORBILLIFORM 3 0.0011
206 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
207 COMMUNICATION DISORDER 4 0.0010
208 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
209 NAIL DISORDER 9 0.0010
210 RHINOVIRUS INFECTION 4 0.0010
211 VITAMIN D DEFICIENCY 10 0.0010
212 SPINAL OSTEOARTHRITIS 9 0.0010
213 HOSPICE CARE 10 0.0010
214 HAEMATOCRIT DECREASED 20 0.0010
215 TRICUSPID VALVE INCOMPETENCE 8 0.0010
216 TINNITUS 46 0.0010
217 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
218 EYELID PTOSIS 10 0.0010
219 BRADYCARDIA 52 0.0010
220 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
221 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
222 EAR PAIN 19 0.0010
223 FEMORAL NECK FRACTURE 5 0.0010
224 PERIPHERAL VASCULAR DISORDER 5 0.0010
225 BLOOD CREATININE DECREASED 3 0.0010
226 RESPIRATORY RATE DECREASED 3 0.0010
227 BLEPHAROSPASM 6 0.0010
228 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
229 IRIDOCYCLITIS 3 0.0009
230 POLYMYALGIA RHEUMATICA 3 0.0009
231 CUSHINGOID 3 0.0009
232 OVERWEIGHT 5 0.0009
233 DIVERTICULUM INTESTINAL 4 0.0009
234 GINGIVAL SWELLING 4 0.0009
235 PEPTIC ULCER 3 0.0009
236 OLIGOHYDRAMNIOS 3 0.0009
237 FACIAL PAIN 8 0.0009
238 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
239 HEPATIC CYST 3 0.0009
240 MITRAL VALVE INCOMPETENCE 10 0.0009
241 DIABETIC RETINOPATHY 3 0.0009
242 ECCHYMOSIS 6 0.0009
243 EAR DISORDER 4 0.0009
244 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
245 ONYCHOCLASIS 6 0.0009
246 NEPHROGENIC ANAEMIA 4 0.0009
247 AORTIC STENOSIS 3 0.0009
248 RIGHT VENTRICULAR FAILURE 6 0.0009
249 SEASONAL ALLERGY 12 0.0008
250 HAEMORRHAGIC DIATHESIS 3 0.0008
251 HAEMORRHOIDS 16 0.0008
252 HYPERVOLAEMIA 4 0.0008
253 CONJUNCTIVITIS 15 0.0008
254 MALNUTRITION 9 0.0008
255 DISCOMFORT 49 0.0008
256 HYPERNATRAEMIA 4 0.0008
257 BLOOD CALCIUM INCREASED 7 0.0008
258 PROTEIN TOTAL DECREASED 3 0.0008
259 SNORING 3 0.0008
260 TROPONIN INCREASED 6 0.0008
261 DYSLIPIDAEMIA 4 0.0008
262 ACUTE RESPIRATORY FAILURE 15 0.0008
263 INCREASED UPPER AIRWAY SECRETION 4 0.0008
264 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
265 TRISMUS 4 0.0008
266 LEUKOCYTOSIS 14 0.0008
267 CATARACT 46 0.0008
268 FAECES HARD 3 0.0008
269 PELVIC FRACTURE 6 0.0008
270 MULTIPLE ALLERGIES 6 0.0008
271 STEVENS-JOHNSON SYNDROME 17 0.0008
272 RESPIRATORY ACIDOSIS 3 0.0008
273 PNEUMONIA FUNGAL 3 0.0008
274 EYE DISORDER 25 0.0008
275 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
276 NYSTAGMUS 4 0.0008
277 HYPERLIPIDAEMIA 9 0.0008
278 CEREBRAL ATROPHY 3 0.0008
279 MULTI-ORGAN FAILURE 13 0.0008
280 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
281 FOREIGN BODY 3 0.0007
282 FUNGAL SKIN INFECTION 3 0.0007
283 VITAMIN B12 DEFICIENCY 3 0.0007
284 DECUBITUS ULCER 6 0.0007
285 OESOPHAGITIS 8 0.0007
286 DIPLOPIA 19 0.0007
287 EYE MOVEMENT DISORDER 5 0.0007
288 HYPERURICAEMIA 3 0.0007
289 ATELECTASIS 7 0.0007
290 GASTRIC ULCER HAEMORRHAGE 4 0.0007
291 ANGIOPATHY 4 0.0007
292 INFUSION SITE ERYTHEMA 6 0.0007
293 EXPOSURE DURING PREGNANCY 44 0.0007
294 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
295 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
296 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
297 BLOOD MAGNESIUM DECREASED 6 0.0007
298 HIATUS HERNIA 9 0.0007
299 EXERCISE TOLERANCE DECREASED 4 0.0007
300 EMPHYSEMA 7 0.0007
301 DERMATITIS BULLOUS 5 0.0007
302 DEVICE USE ISSUE 12 0.0007
303 HAEMORRHAGIC ANAEMIA 3 0.0007
304 SLEEP APNOEA SYNDROME 13 0.0007
305 IMMUNOSUPPRESSION 6 0.0007
306 ILEUS PARALYTIC 3 0.0007
307 HYPOKALAEMIA 31 0.0007
308 IRON DEFICIENCY 3 0.0007
309 GANGRENE 4 0.0007
310 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
311 ECONOMIC PROBLEM 10 0.0007
312 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
313 RENAL FAILURE CHRONIC 5 0.0006
314 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
315 LOCALISED OEDEMA 3 0.0006
316 HYPOMAGNESAEMIA 9 0.0006
317 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
318 NASAL DRYNESS 4 0.0006
319 INFUSION SITE SWELLING 4 0.0006
320 SKIN ABRASION 3 0.0006
321 NASAL DISCOMFORT 5 0.0006
322 RENAL CYST 5 0.0006
323 SUBCUTANEOUS ABSCESS 3 0.0006
324 HYPOXIA 22 0.0006
325 GLAUCOMA 12 0.0006
326 HUMERUS FRACTURE 3 0.0006
327 PROCTALGIA 4 0.0006
328 RHINITIS 5 0.0006
329 BREATH SOUNDS ABNORMAL 3 0.0006
330 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
331 ABDOMINAL TENDERNESS 3 0.0006
332 MADAROSIS 7 0.0006
333 EOSINOPHIL COUNT INCREASED 5 0.0006
334 VEIN DISORDER 3 0.0006
335 EYE HAEMORRHAGE 8 0.0006
336 SENSATION OF FOREIGN BODY 5 0.0006
337 POSTOPERATIVE WOUND INFECTION 4 0.0006
338 HEPATIC STEATOSIS 11 0.0006
339 BACTERAEMIA 7 0.0006
340 VISUAL IMPAIRMENT 73 0.0006
341 PETIT MAL EPILEPSY 3 0.0006
342 ENDOCARDITIS 3 0.0006
343 NEPHROTIC SYNDROME 4 0.0006
344 VARICOSE VEIN 3 0.0006
345 SKIN ULCER 15 0.0006
346 HYPERBILIRUBINAEMIA 6 0.0006
347 PROTEINURIA 11 0.0006
348 PERIORBITAL OEDEMA 3 0.0006
349 MENTAL STATUS CHANGES 16 0.0006
350 APLASTIC ANAEMIA 3 0.0006
351 RHINORRHOEA 37 0.0006
352 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
353 SMALL INTESTINAL OBSTRUCTION 7 0.0006
354 LYMPHOCYTE COUNT DECREASED 10 0.0006
355 BLOOD POTASSIUM DECREASED 17 0.0006
356 ILEUS 7 0.0006
357 BODY HEIGHT DECREASED 6 0.0006
358 GRAFT VERSUS HOST DISEASE 4 0.0006
359 DISABILITY 11 0.0006
360 FLUID OVERLOAD 8 0.0005
361 METASTASES TO BONE 9 0.0005
362 MOUTH HAEMORRHAGE 4 0.0005
363 RETINAL DETACHMENT 5 0.0005
364 INCREASED TENDENCY TO BRUISE 5 0.0005
365 HYPOPHOSPHATAEMIA 4 0.0005
366 COAGULOPATHY 9 0.0005
367 PLATELET COUNT INCREASED 7 0.0005
368 SNEEZING 12 0.0005
369 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
370 DEFORMITY 5 0.0005
371 SKIN INFECTION 6 0.0005
372 PRODUCT LEAKAGE 3 0.0005
373 INCORRECT PRODUCT STORAGE 7 0.0005
374 EMOTIONAL DISTRESS 64 0.0005
375 DERMATITIS CONTACT 6 0.0005
376 AORTIC ANEURYSM 4 0.0005
377 HAEMODYNAMIC INSTABILITY 4 0.0005
378 RED BLOOD CELL COUNT DECREASED 15 0.0005
379 ACIDOSIS 4 0.0005
380 LIPASE INCREASED 4 0.0005
381 GASTRIC HAEMORRHAGE 6 0.0005
382 SINUS CONGESTION 7 0.0005
383 UVEITIS 7 0.0005
384 APHTHOUS ULCER 4 0.0005
385 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
386 THERAPY PARTIAL RESPONDER 8 0.0005
387 HYPERTRIGLYCERIDAEMIA 3 0.0005
388 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
389 HEPATOMEGALY 5 0.0005
390 DECREASED INTEREST 3 0.0005
391 CATARACT OPERATION 3 0.0005
392 SINUS HEADACHE 3 0.0005
393 BURSITIS 6 0.0005
394 SHOCK HAEMORRHAGIC 4 0.0005
395 BLINDNESS 20 0.0005
396 CYTOPENIA 6 0.0005
397 CARDIOMEGALY 6 0.0005
398 PHARYNGITIS 6 0.0005
399 HYPERTHYROIDISM 7 0.0005
400 SEPTIC SHOCK 21 0.0005
401 INFUSION SITE EXTRAVASATION 3 0.0005
402 EMBOLISM 4 0.0005
403 TENDERNESS 5 0.0005
404 PETECHIAE 5 0.0005
405 TYPE 2 DIABETES MELLITUS 16 0.0005
406 OSTEOARTHRITIS 20 0.0005
407 HEPATITIS 12 0.0005
408 ROTATOR CUFF SYNDROME 6 0.0005
409 PSEUDOMONAS INFECTION 4 0.0005
410 HAEMOGLOBIN ABNORMAL 3 0.0005
411 INFUSION SITE PAIN 6 0.0005
412 ASPIRATION 5 0.0005
413 GASTRITIS 12 0.0005
414 METASTASES TO LIVER 8 0.0005
415 TOOTH INFECTION 6 0.0005
416 WALKING AID USER 3 0.0005
417 SINUS DISORDER 9 0.0005
418 HYPOTENSION 91 0.0005
419 LUNG INFILTRATION 4 0.0005
420 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
421 CARDIAC FAILURE ACUTE 3 0.0004
422 THERAPY INTERRUPTED 32 0.0004
423 POST-TRAUMATIC STRESS DISORDER 3 0.0004
424 QUALITY OF LIFE DECREASED 6 0.0004
425 BREAST MASS 3 0.0004
426 TASTE DISORDER 9 0.0004
427 VERTIGO 27 0.0004
428 NASAL CONGESTION 26 0.0004
429 TACHYPNOEA 6 0.0004
430 RESPIRATORY TRACT CONGESTION 7 0.0004
431 OBESITY 7 0.0004
432 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
433 SCAB 5 0.0004
434 EXOSTOSIS 4 0.0004
435 CELLULITIS 22 0.0004
436 JOINT EFFUSION 3 0.0004
437 LYMPHOEDEMA 3 0.0004
438 ENCEPHALITIS 3 0.0004
439 IRON DEFICIENCY ANAEMIA 4 0.0004
440 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
441 MUSCLE TIGHTNESS 7 0.0004
442 HYPERTRANSAMINASAEMIA 3 0.0004
443 CARPAL TUNNEL SYNDROME 6 0.0004
444 BLINDNESS UNILATERAL 6 0.0004
445 LACERATION 4 0.0004
446 RESPIRATORY FAILURE 31 0.0004
447 RENAL FAILURE ACUTE 18 0.0004
448 VENTRICULAR TACHYCARDIA 7 0.0004
449 HAND FRACTURE 3 0.0004
450 THERMAL BURN 3 0.0004
451 SPINAL DISORDER 4 0.0004
452 RESPIRATORY TRACT INFECTION 11 0.0004
453 SPUTUM DISCOLOURED 4 0.0004
454 SEPSIS 47 0.0004
455 SINUSITIS 43 0.0004
456 RECALLED PRODUCT ADMINISTERED 4 0.0004
457 BRONCHITIS 31 0.0004
458 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
459 POST PROCEDURAL COMPLICATION 8 0.0004
460 SEROTONIN SYNDROME 8 0.0004
461 VISUAL FIELD DEFECT 3 0.0004
462 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
463 BLOOD CREATININE INCREASED 27 0.0004
464 FAECES SOFT 3 0.0004
465 DIZZINESS POSTURAL 4 0.0004
466 NECK PAIN 23 0.0004
467 ACCIDENTAL OVERDOSE 15 0.0004
468 OXYGEN SATURATION DECREASED 23 0.0004
469 ORAL DISORDER 3 0.0004
470 BLINDNESS TRANSIENT 3 0.0004
471 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
472 FEELING DRUNK 3 0.0004
473 CYST 5 0.0004
474 SKIN LESION 11 0.0004
475 HYDRONEPHROSIS 3 0.0004
476 ATRIAL FIBRILLATION 39 0.0004
477 PNEUMONIA ASPIRATION 10 0.0004
478 HYPOTHERMIA 4 0.0004
479 FEBRILE NEUTROPENIA 26 0.0004
480 BOWEL MOVEMENT IRREGULARITY 3 0.0004
481 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
482 PERICARDIAL EFFUSION 9 0.0004
483 HELICOBACTER INFECTION 4 0.0004
484 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
485 OSTEOMYELITIS 7 0.0004
486 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
487 PULMONARY HYPERTENSION 8 0.0004
488 DEHYDRATION 51 0.0004
489 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
490 DISEASE PROGRESSION 45 0.0004
491 BLOOD ALBUMIN DECREASED 3 0.0004
492 GINGIVAL PAIN 3 0.0004
493 SCIATICA 6 0.0004
494 ASCITES 11 0.0004
495 HIP FRACTURE 12 0.0004
496 DYSPNOEA EXERTIONAL 14 0.0004
497 NEURALGIA 9 0.0004
498 HYPOCALCAEMIA 7 0.0004
499 DRY MOUTH 30 0.0004
500 GASTRIC ULCER 7 0.0004
501 SKIN LACERATION 4 0.0004
502 DRUG TOXICITY 5 0.0004
503 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
504 ACUTE KIDNEY INJURY 56 0.0004
505 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
506 ESCHERICHIA INFECTION 3 0.0004
507 LOWER LIMB FRACTURE 7 0.0004
508 PHOTOSENSITIVITY REACTION 6 0.0004
509 SPINAL COMPRESSION FRACTURE 3 0.0004
510 RESPIRATORY DISTRESS 10 0.0004
511 DENTAL CARIES 4 0.0004
512 DIVERTICULITIS 10 0.0004
513 EPILEPSY 11 0.0004
514 DYSPHAGIA 34 0.0004
515 PANCYTOPENIA 20 0.0004
516 URINARY TRACT INFECTION 61 0.0004
517 NEPHROPATHY TOXIC 4 0.0004
518 CANDIDA INFECTION 6 0.0004
519 MUSCLE SPASMS 65 0.0004
520 HYPOPHAGIA 9 0.0004
521 IMPAIRED DRIVING ABILITY 4 0.0004
522 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
523 HEAD INJURY 11 0.0003
524 EPISTAXIS 26 0.0003
525 PARAESTHESIA ORAL 5 0.0003
526 PYELONEPHRITIS 3 0.0003
527 PLEURAL EFFUSION 21 0.0003
528 HYPOTHYROIDISM 11 0.0003
529 ANXIETY 98 0.0003
530 VASCULITIS 4 0.0003
531 COLITIS 13 0.0003
532 HEART RATE DECREASED 12 0.0003
533 TUMOUR LYSIS SYNDROME 3 0.0003
534 HAEMOGLOBIN DECREASED 35 0.0003
535 RIB FRACTURE 7 0.0003
536 LYMPHADENOPATHY 12 0.0003
537 DEEP VEIN THROMBOSIS 22 0.0003
538 BLISTER 19 0.0003
539 RESPIRATORY RATE INCREASED 3 0.0003
540 OEDEMA PERIPHERAL 41 0.0003
541 PULMONARY MASS 5 0.0003
542 BALANCE DISORDER 29 0.0003
543 PULMONARY OEDEMA 15 0.0003
544 MACULAR DEGENERATION 4 0.0003
545 FEAR 9 0.0003
546 MYOSITIS 3 0.0003
547 STAPHYLOCOCCAL INFECTION 11 0.0003
548 CONTUSION 32 0.0003
549 OROPHARYNGEAL DISCOMFORT 3 0.0003
550 HALLUCINATION, VISUAL 7 0.0003
551 LOCALISED INFECTION 8 0.0003
552 ADRENAL INSUFFICIENCY 4 0.0003
553 NOCTURIA 4 0.0003
554 CHRONIC KIDNEY DISEASE 25 0.0003
555 LIVER FUNCTION TEST INCREASED 7 0.0003
556 DYSURIA 12 0.0003
557 UROSEPSIS 3 0.0003
558 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
559 THYROID DISORDER 5 0.0003
560 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
561 OROPHARYNGEAL PAIN 30 0.0003
562 HYPERCALCAEMIA 4 0.0003
563 PRODUCT DISTRIBUTION ISSUE 3 0.0003
564 TENDONITIS 5 0.0003
565 HAEMATURIA 11 0.0003
566 DIARRHOEA HAEMORRHAGIC 3 0.0003
567 ACUTE MYELOID LEUKAEMIA 5 0.0003
568 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
569 FLANK PAIN 3 0.0003
570 HYPONATRAEMIA 18 0.0003
571 SECRETION DISCHARGE 4 0.0003
572 ARTERIOSCLEROSIS 3 0.0003
573 BLOOD SODIUM DECREASED 6 0.0003
574 LEUKAEMIA 3 0.0003
575 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
576 PNEUMOTHORAX 5 0.0003
577 HYPERKALAEMIA 11 0.0003
578 SINUS BRADYCARDIA 3 0.0003
579 SYNCOPE 31 0.0003
580 LACTIC ACIDOSIS 10 0.0003
581 BLOOD POTASSIUM INCREASED 5 0.0003
582 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
583 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
584 MUCOSAL INFLAMMATION 8 0.0003
585 ACUTE MYOCARDIAL INFARCTION 9 0.0003
586 ARTHRITIS 24 0.0003
587 THERAPY CHANGE 3 0.0003
588 THROMBOCYTOPENIA 34 0.0003
589 MUSCLE TWITCHING 7 0.0003
590 IMMUNE SYSTEM DISORDER 4 0.0003
591 FALL 101 0.0003
592 PULMONARY CONGESTION 4 0.0003
593 CARDIAC ARREST 25 0.0003
594 CONSTIPATION 66 0.0003
595 HYPOTONIA 3 0.0003
596 BLOOD CHOLESTEROL INCREASED 14 0.0003
597 SKIN DISORDER 10 0.0003
598 COGNITIVE DISORDER 14 0.0003
599 PRODUCT DOSE OMISSION ISSUE 88 0.0003
600 CARDIAC FAILURE CONGESTIVE 24 0.0003
601 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
602 TOOTH ABSCESS 3 0.0003
603 SLUGGISHNESS 3 0.0003
604 IMPAIRED GASTRIC EMPTYING 4 0.0003
605 TEMPERATURE INTOLERANCE 3 0.0003
606 VENTRICULAR EXTRASYSTOLES 3 0.0003
607 FIBROMYALGIA 7 0.0003
608 ORAL DISCOMFORT 4 0.0003
609 POLLAKIURIA 12 0.0003
610 CYSTITIS 9 0.0003
611 PAIN IN JAW 8 0.0003
612 NASOPHARYNGITIS 52 0.0003
613 SINUS TACHYCARDIA 4 0.0003
614 TACHYCARDIA 25 0.0003
615 BREAST PAIN 3 0.0003
616 BLOOD GLUCOSE INCREASED 53 0.0003
617 PNEUMONIA 91 0.0003
618 LOSS OF CONSCIOUSNESS 36 0.0003
619 BRONCHOSPASM 4 0.0003
620 THIRST 5 0.0003
621 HYPOACUSIS 12 0.0003
622 GOUT 5 0.0003
623 LETHARGY 16 0.0003
624 PHARYNGITIS STREPTOCOCCAL 3 0.0003
625 GASTROENTERITIS VIRAL 5 0.0003
626 ANOSMIA 4 0.0003
627 INJECTION SITE HAEMATOMA 4 0.0003
628 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
629 RESTLESS LEGS SYNDROME 5 0.0003
630 END STAGE RENAL DISEASE 5 0.0003
631 GASTROINTESTINAL PAIN 3 0.0003
632 ANAEMIA 52 0.0003
633 MELAENA 6 0.0003
634 WEIGHT DECREASED 76 0.0003
635 TOOTH FRACTURE 3 0.0003
636 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 55 0.0003
637 ASTHENIA 102 0.0003
638 UNRESPONSIVE TO STIMULI 7 0.0003
639 HEADACHE 170 0.0003
640 VIRAL INFECTION 9 0.0003
641 INJURY 19 0.0003
642 NERVE INJURY 3 0.0003
643 URINARY RETENTION 9 0.0003
644 RASH MACULO-PAPULAR 6 0.0003
645 INFLUENZA 30 0.0003
646 GASTROINTESTINAL DISORDER 24 0.0003
647 ANHEDONIA 7 0.0003
648 HYPOAESTHESIA ORAL 4 0.0003
649 DYSPEPSIA 26 0.0003
650 CORONARY ARTERY DISEASE 8 0.0003
651 COUGH 74 0.0003
652 OSTEOPENIA 4 0.0003
653 NEUROPATHY PERIPHERAL 25 0.0003
654 SHOCK 6 0.0003
655 DIZZINESS 130 0.0003
656 CONFUSIONAL STATE 42 0.0003
657 DEVICE RELATED INFECTION 4 0.0003
658 HYPERSENSITIVITY 48 0.0003
659 COVID-19 PNEUMONIA 3 0.0003
660 CHEST PAIN 47 0.0003
661 PLATELET COUNT DECREASED 27 0.0003
662 ARTHROPATHY 14 0.0003
663 FEELING COLD 7 0.0003
664 PRODUCTIVE COUGH 12 0.0003
665 HAEMOPTYSIS 7 0.0003
666 DEMENTIA 7 0.0003
667 WOUND 7 0.0003
668 SENSORY DISTURBANCE 4 0.0002
669 FULL BLOOD COUNT DECREASED 5 0.0002
670 SCHIZOPHRENIA 3 0.0002
671 BACK DISORDER 4 0.0002
672 DYSPNOEA 139 0.0002
673 HYPERTENSION 52 0.0002
674 BACK PAIN 57 0.0002
675 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
676 THROAT IRRITATION 11 0.0002
677 MUSCLE SPASTICITY 3 0.0002
678 IMPAIRED HEALING 8 0.0002
679 PERITONITIS 5 0.0002
680 MIGRAINE 23 0.0002
681 RHABDOMYOLYSIS 10 0.0002
682 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
683 DERMATITIS 5 0.0002
684 PAIN 146 0.0002
685 LABORATORY TEST ABNORMAL 7 0.0002
686 PRODUCT COMPLAINT 6 0.0002
687 THROMBOSIS 19 0.0002
688 IMPAIRED WORK ABILITY 5 0.0002
689 MYDRIASIS 3 0.0002
690 PERIPHERAL SWELLING 36 0.0002
691 RENAL FAILURE 31 0.0002
692 MUSCULOSKELETAL DISCOMFORT 4 0.0002
693 DRY SKIN 31 0.0002
694 PARANOIA 4 0.0002
695 APHASIA 7 0.0002
696 CHILLS 27 0.0002
697 MULTIPLE SCLEROSIS 11 0.0002
698 ORTHOSTATIC HYPOTENSION 4 0.0002
699 DEAFNESS 6 0.0002
700 BLOOD PRESSURE INCREASED 35 0.0002
701 NEUROTOXICITY 4 0.0002
702 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
703 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
704 ANGIOEDEMA 10 0.0002
705 HEAD DISCOMFORT 4 0.0002
706 UNEVALUABLE EVENT 17 0.0002
707 CHEST DISCOMFORT 23 0.0002
708 LUNG DISORDER 11 0.0002
709 FATIGUE 174 0.0002
710 RASH PAPULAR 5 0.0002
711 DISTURBANCE IN ATTENTION 12 0.0002
712 THERAPY NON-RESPONDER 10 0.0002
713 HEART RATE INCREASED 22 0.0002
714 DYSKINESIA 9 0.0002
715 TOOTHACHE 4 0.0002
716 PRODUCT QUALITY ISSUE 30 0.0002
717 NEUTROPENIA 30 0.0002
718 MUSCULAR WEAKNESS 25 0.0002
719 GINGIVAL BLEEDING 3 0.0002
720 BONE DISORDER 4 0.0002
721 TREATMENT NONCOMPLIANCE 12 0.0002
722 OSTEOPOROSIS 9 0.0002
723 PERIPHERAL COLDNESS 3 0.0002
724 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
725 ROAD TRAFFIC ACCIDENT 9 0.0002
726 SWELLING FACE 14 0.0002
727 APHONIA 3 0.0002
728 HOSPITALISATION 33 0.0002
729 MASS 3 0.0002
730 STOMATITIS 13 0.0002
731 CHOLELITHIASIS 7 0.0002
732 HEPATIC CIRRHOSIS 4 0.0002
733 SLEEP DISORDER 15 0.0002
734 BLOOD URINE PRESENT 4 0.0002
735 BLOOD PRESSURE DECREASED 14 0.0002
736 SPEECH DISORDER 11 0.0002
737 SUBDURAL HAEMATOMA 3 0.0002
738 INCREASED APPETITE 4 0.0002
739 HYPERSOMNIA 6 0.0002
740 BLOOD PRESSURE FLUCTUATION 5 0.0002
741 INSOMNIA 55 0.0002
742 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
743 OEDEMA 11 0.0002
744 WHEEZING 12 0.0002
745 RENAL INJURY 6 0.0002
746 DISORIENTATION 8 0.0002
747 HAEMORRHAGE INTRACRANIAL 3 0.0002
748 MYALGIA 34 0.0002
749 CYTOKINE RELEASE SYNDROME 4 0.0002
750 PRODUCT DOSE OMISSION 13 0.0002
751 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
752 HAEMATEMESIS 5 0.0002
753 FEEDING DISORDER 4 0.0002
754 DIARRHOEA 127 0.0002
755 MEMORY IMPAIRMENT 27 0.0002
756 INSURANCE ISSUE 3 0.0002
757 CEREBROVASCULAR ACCIDENT 33 0.0002
758 THERAPY CESSATION 10 0.0002
759 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
760 ANAPHYLACTIC SHOCK 5 0.0002
761 MUSCULOSKELETAL CHEST PAIN 3 0.0002
762 ANKLE FRACTURE 3 0.0002
763 INFLAMMATION 10 0.0002
764 FEMUR FRACTURE 6 0.0002
765 RASH GENERALISED 5 0.0002
766 BASAL CELL CARCINOMA 3 0.0002
767 ABDOMINAL DISCOMFORT 32 0.0002
768 CYANOSIS 3 0.0002
769 PYREXIA 66 0.0002
770 AGITATION 14 0.0002
771 DECREASED APPETITE 44 0.0002
772 DISEASE RECURRENCE 9 0.0002
773 ABDOMINAL PAIN 44 0.0002
774 DYSPHONIA 11 0.0002
775 EATING DISORDER 4 0.0002
776 PALPITATIONS 22 0.0002
777 BONE PAIN 11 0.0002
778 METABOLIC ACIDOSIS 6 0.0002
779 BLOOD GLUCOSE DECREASED 9 0.0002
780 JOINT INJURY 4 0.0002
781 INFECTION 27 0.0002
782 HYPERHIDROSIS 24 0.0002
783 RECTAL HAEMORRHAGE 8 0.0002
784 RASH 81 0.0002
785 HOT FLUSH 14 0.0002
786 PAIN OF SKIN 5 0.0002
787 BURNING SENSATION 13 0.0002
788 BLOOD BILIRUBIN INCREASED 5 0.0002
789 FAECES DISCOLOURED 4 0.0002
790 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
791 PALLOR 5 0.0002
792 DIABETES MELLITUS 14 0.0002
793 GAIT DISTURBANCE 35 0.0002
794 MULTIPLE FRACTURES 3 0.0002
795 CARDIAC DISORDER 17 0.0002
796 SWELLING 17 0.0002
797 DRUG DOSE OMISSION 30 0.0002
798 RESPIRATORY ARREST 5 0.0002
799 TREMOR 30 0.0002
800 EXPIRED PRODUCT ADMINISTERED 6 0.0002
801 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
802 FUNGAL INFECTION 6 0.0002
803 ORAL PAIN 4 0.0002
804 PERICARDITIS 3 0.0002
805 FACE OEDEMA 3 0.0002
806 SKIN EXFOLIATION 15 0.0002
807 HEMIPARESIS 3 0.0002
808 HEART RATE IRREGULAR 4 0.0002
809 FLUID RETENTION 9 0.0002
810 FLATULENCE 10 0.0002
811 DEPRESSION 40 0.0002
812 PRODUCT AVAILABILITY ISSUE 4 0.0002
813 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
814 NEPHROLITHIASIS 8 0.0002
815 CARDIAC FAILURE 14 0.0002
816 SKIN DISCOLOURATION 8 0.0002
817 HERPES ZOSTER 10 0.0002
818 JOINT SWELLING 21 0.0002
819 HYPOAESTHESIA 26 0.0002
820 NIGHTMARE 6 0.0002
821 NERVOUSNESS 9 0.0002
822 HAEMORRHAGE 18 0.0002
823 NAUSEA 136 0.0002
824 RASH MACULAR 6 0.0002
825 INTENTIONAL PRODUCT MISUSE 15 0.0002
826 CONDITION AGGRAVATED 52 0.0002
827 COVID-19 30 0.0002
828 ERYTHEMA 35 0.0002
829 DEPRESSED MOOD 9 0.0002
830 COLD SWEAT 3 0.0002
831 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
832 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
833 URINARY INCONTINENCE 5 0.0002
834 RHEUMATOID ARTHRITIS 19 0.0002
835 RASH ERYTHEMATOUS 8 0.0002
836 RESPIRATORY DISORDER 5 0.0002
837 ARTHRALGIA 69 0.0002
838 HEPATIC FAILURE 5 0.0002
839 PARAESTHESIA 26 0.0002
840 PELVIC PAIN 3 0.0002
841 CEREBRAL INFARCTION 4 0.0002
842 ENCEPHALOPATHY 4 0.0002
843 OSTEONECROSIS OF JAW 4 0.0002
844 BACTERIAL INFECTION 3 0.0002
845 AGEUSIA 4 0.0002
846 ABDOMINAL PAIN UPPER 33 0.0002
847 LEUKOPENIA 8 0.0002
848 MUSCULOSKELETAL STIFFNESS 14 0.0002
849 FRACTURE 3 0.0002
850 FOOT FRACTURE 3 0.0002
851 PULMONARY FIBROSIS 3 0.0002
852 ERECTILE DYSFUNCTION 4 0.0002
853 MALAISE 68 0.0002
854 RENAL IMPAIRMENT 13 0.0002
855 EXPOSURE VIA SKIN CONTACT 4 0.0002
856 SOMNOLENCE 31 0.0002
857 CHOKING 3 0.0002
858 ALOPECIA 30 0.0002
859 SEDATION 4 0.0002
860 JOINT STIFFNESS 4 0.0002
861 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
862 ABNORMAL BEHAVIOUR 6 0.0002
863 VOMITING 71 0.0002
864 PRURITUS 58 0.0002
865 INFUSION RELATED REACTION 10 0.0002
866 UNDERDOSE 11 0.0002
867 UPPER LIMB FRACTURE 3 0.0002
868 EAR INFECTION 4 0.0002
869 SPINAL FRACTURE 3 0.0001
870 IRRITABILITY 9 0.0001
871 PAIN IN EXTREMITY 44 0.0001
872 URTICARIA 25 0.0001
873 BONE MARROW FAILURE 3 0.0001
874 RASH PRURITIC 8 0.0001
875 NEUTROPHIL COUNT DECREASED 6 0.0001
876 PNEUMONITIS 4 0.0001
877 FEELING HOT 9 0.0001
878 OFF LABEL USE 128 0.0001
879 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
880 GASTRIC DISORDER 5 0.0001
881 HAEMATOCHEZIA 8 0.0001
882 TREATMENT FAILURE 12 0.0001
883 TOOTH LOSS 3 0.0001
884 PRODUCT USE ISSUE 27 0.0001
885 CARDIO-RESPIRATORY ARREST 6 0.0001
886 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
887 DRUG INEFFECTIVE 186 0.0001
888 RETCHING 3 0.0001
889 IRRITABLE BOWEL SYNDROME 3 0.0001
890 CONVULSION 8 0.0001
891 POOR QUALITY SLEEP 3 0.0001
892 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
893 DRUG INTERACTION 22 0.0001
894 SEIZURE 16 0.0001
895 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
896 HYPERGLYCAEMIA 5 0.0001
897 PRODUCT STORAGE ERROR 12 0.0001
898 DYSSTASIA 4 0.0001
899 PULMONARY EMBOLISM 13 0.0001
900 APPLICATION SITE PAIN 3 0.0001
901 TOOTH DISORDER 3 0.0001
902 NEOPLASM MALIGNANT 9 0.0001
903 GLOSSODYNIA 3 0.0001
904 WEIGHT INCREASED 30 0.0001
905 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
906 INFLUENZA LIKE ILLNESS 11 0.0001
907 MUSCULOSKELETAL PAIN 7 0.0001
908 INTESTINAL OBSTRUCTION 5 0.0001
909 FEELING ABNORMAL 31 0.0001
910 BREAST CANCER 12 0.0001
911 SWOLLEN TONGUE 4 0.0001
912 ANAPHYLACTIC REACTION 7 0.0001
913 MOBILITY DECREASED 9 0.0001
914 MOVEMENT DISORDER 4 0.0001
915 NIGHT SWEATS 4 0.0001
916 INTERSTITIAL LUNG DISEASE 6 0.0001
917 HYPOGLYCAEMIA 6 0.0001
918 AMNESIA 8 0.0001
919 OSTEONECROSIS 4 0.0001
920 ABASIA 3 0.0001
921 LIP SWELLING 4 0.0001
922 SURGERY 7 0.0001
923 CARDIOVASCULAR DISORDER 3 0.0001
924 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
925 HAEMATOMA 3 0.0001
926 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
927 ABDOMINAL DISTENSION 12 0.0001
928 MENTAL DISORDER 5 0.0001
929 ECZEMA 6 0.0001
930 DEATH 98 0.0001
931 PANCREATITIS 6 0.0001
932 LIVER DISORDER 5 0.0001
933 CEREBRAL HAEMORRHAGE 4 0.0001
934 JAUNDICE 3 0.0001
935 MOOD ALTERED 3 0.0001
936 SUICIDAL IDEATION 10 0.0001
937 SKIN IRRITATION 5 0.0001
938 FLUSHING 11 0.0001
939 PROCEDURAL PAIN 3 0.0001
940 MEDICATION ERROR 6 0.0001
941 ASTHMA 12 0.0001
942 HALLUCINATION 8 0.0001
943 LIVER FUNCTION TEST ABNORMAL 3 0.0001
944 NEEDLE ISSUE 3 0.0001
945 PLASMA CELL MYELOMA 4 0.0001
946 AGGRESSION 5 0.0001
947 PREMATURE BABY 3 0.0001
948 DRUG ADMINISTRATION ERROR 3 0.0001
949 ILLNESS 10 0.0001
950 LIMB DISCOMFORT 3 0.0001
951 DYSGEUSIA 7 0.0001
952 INCORRECT DOSE ADMINISTERED 21 0.0001
953 GAIT INABILITY 3 0.0001
954 ADVERSE DRUG REACTION 8 0.0001
955 DELIRIUM 3 0.0001
956 NEOPLASM PROGRESSION 3 0.0001
957 MYOCARDIAL INFARCTION 15 0.0001
958 RENAL DISORDER 4 0.0001
959 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
960 THERAPEUTIC RESPONSE DECREASED 5 0.0001
961 C-REACTIVE PROTEIN INCREASED 3 0.0001
962 DYSARTHRIA 3 0.0001
963 ACNE 6 0.0001
964 ADVERSE EVENT 7 0.0001
965 DEVICE DIFFICULT TO USE 5 0.0001
966 EXTRA DOSE ADMINISTERED 3 0.0001
967 DEVICE DISLOCATION 3 0.0001
968 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
969 INJECTION SITE ERYTHEMA 8 0.0001
970 ARRHYTHMIA 3 0.0001
971 COMA 3 0.0001
972 INJECTION SITE BRUISING 5 0.0001
973 INJECTION SITE PAIN 18 0.0001
974 HEPATIC ENZYME INCREASED 4 0.0001
975 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
976 DEVICE MALFUNCTION 4 0.0001
977 DEVICE ISSUE 5 0.0001
978 DRUG EFFECT DECREASED 3 0.0001
979 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
980 PSORIASIS 7 0.0001
981 DRUG INTOLERANCE 5 0.0001
982 OVERDOSE 11 0.0001
983 NO ADVERSE EVENT 9 0.0000
984 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
985 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
986 INJECTION SITE SWELLING 3 0.0000
987 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
988 DRUG ABUSE 3 0.0000
989 DRUG WITHDRAWAL SYNDROME 3 0.0000
990 DRUG DEPENDENCE 4 0.0000
991 TOXICITY TO VARIOUS AGENTS 4 0.0000